Enhertu 100 mg Injection is administered intravenously (into a vein) by a healthcare provider on scheduled appointments.
The frequency, duration, and dosage of the treatment are determined by the healthcare provider based on the severity of the disease and other considerations.
Contraindications:
Do not take this medication if you are allergic to Enhertu 100 mg Injection or its components.
Not recommended for anyone under 18 years old.
Inform your doctor if you have any breathing issues or a serious lung problem.
Tell your doctor if you have any kidney, liver, or heart problems or any other underlying health issues.
Safety advices:
Pregnancy: Enhertu 100 mg Injection can cause neonatal complications. Not recommended during pregnancy, planning for pregnancy, or if you think you may become pregnant.
Breastfeeding: Enhertu 100 mg Injection in nursing mothers has not been studied. Not recommended for breastfeeding mothers.
Lungs: If you have a history of lung disease, you may be at a higher risk of developing interstitial lung disease when using Enhertu 100 mg Injection.
Liver: Before beginning treatment, inform your doctor if you suffer from liver impairment.
Alcohol: Enhertu 100 mg Injection is not known to interact with alcohol. However, both can have similar side effects, such as headaches and nausea.
Driving: Enhertu 100 mg Injection does not impair your ability to drive or operate machinery. However, be cautious if you feel dizzy, tired, or have a headache.
Side effects:
Serious: severe allergic reactions (rashes, itching, difficulty in breathing, fever).
Common: nausea (feeling sick), vomiting, tiredness, decreased appetite, blood tests showing decreased red or white blood cells or platelets, hair loss, diarrhoea, constipation, blood tests showing increased levels of the liver enzymes such as transaminases, pain in muscles and bones, weight loss, fever, abdominal (belly) pain, infections of the nose and throat, including flu-like symptoms, headache, blisters in or around your mouth, cough, blood tests showing low blood potassium levels, indigestion, breathing difficulties, swelling of ankles and feet, nosebleed, altered/bad taste in the mouth, infection of the lungs.
Storage:
Store in the refrigerator between 2°C to 8°C.
Do not freeze.
Keep away from children and pets.
FAQ:
Can I continue my regular activities while undergoing treatment with Enhertu 100 mg Injection?
Most patients can maintain their normal activities while on Enhertu 100 mg Injection. However, you should monitor how you feel closely. Side effects like fatigue, nausea, or other symptoms might necessitate adjustments to your daily routine. Always consult your healthcare provider for personalized advice based on your situation.
Will Enhertu 100 mg Injection affect my fertility?
Enhertu 100 mg Injection may have an impact on fertility. If you are planning to have children in the future, it's crucial to discuss this with your healthcare provider before starting treatment. They may suggest fertility preservation options and provide guidance tailored to your personal and family plans.
Are there any foods to avoid while undergoing treatment with Enhertu 100 mg Injection?
While on Enhertu 100 mg Injection, managing nausea and vomiting is important. It's advisable to avoid foods that could aggravate these symptoms, such as heavy, greasy, or fatty foods and spicy or acidic items like lemons, tomatoes, and oranges.
How long does adjuvant therapy with Enhertu 100 mg Injection typically last for HER2-positive early breast cancer?
Based on the findings from four major studies, the standard treatment for patients with HER2-positive early breast cancer involves taking adjuvant Enhertu 100 mg Injection for one year alongside chemotherapy.
What is the success rate of Enhertu 100 mg Injection in treating breast cancer?
The success of Enhertu 100 mg Injection in treating breast cancer is significant. Clinical studies have shown that the five-year invasive breast cancer-free survival rate is 97.4% among patients treated with trastuzumab.
